A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 study of ruxolitinib in combination with azacitidine in patients with myelofibrosis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry